ClinicalTrials.gg
Enrolling by invitationNCT07102654Updated Nov 16, 2026

Comparison Between Digital Nerve Microanastomosis and Traction Neurectomy in Post-Digital Amputation Pain

An observational study in Amputation Stump, Amputation Neuroma and Amputation, Traumatic/Surgery, sponsored by Centre hospitalier de l'Université de Montréal (CHUM). Enrolling by invitation at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Centre hospitalier de l'Université de Montréal (CHUM) · Observational

How we know

Updated Nov 16, 2026Now Enrolling by invitationFirst site in Canada+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this prospective observational study is to assess the post-operative pain in adults with digital amputation following two different surgical interventions: microanastomosis of digital nerves or traction neurectomy. The main questions it aims to answer are:

  • Which surgical intervention results in less post-operative pain?
  • Which surgical intervention leads to fewer symptoms after six months?
  • Which surgical intervention is associated with fewest post-operative complications? Participants will complete a Visual Analog Scale (VAS) to assess the pain and the Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH) to evaluate the disabilities.

The researchers will assess post-operative complications during follow-up appointments.

02

Conditions studied

  • Amputation Stump
  • Amputation Neuroma
  • Amputation, Traumatic/Surgery
  • Amputation, Surgical

Keywords

  • microanastomosis
  • traction neurectomy
  • digital amputation
  • digital nerve
03

In context

Amputation, Traumatic

112 studies on the registry are indexed under Amputation, Traumatic; 24 are open to participants now.

This study's planned enrollment of 50 is above the median of 37 across 34 observational studies indexed under Amputation, Traumatic.

Browse Amputation, Traumatic studies →

Lead sponsor

Centre hospitalier de l'Université de Montréal (CHUM) is the lead sponsor of 376 studies on the registry; 110 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals presenting at the Centre Hospitalier de l'Université de Montréal for a digital amputation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Patients who have undergone a traumatic digital amputation
  • Patients treated with one of the two following techniques: microanastomosis of digital nerves or traction neurectomy
  • Postoperative follow-up of at least 6 months

Exclusion criteria

Exclusion Criteria:

  • Patients treated with a surgical intervention other than microanastomosis of digital nerves or traction neurectomy for digital amputation
  • Non-traumatic amputations (e.g., cancer or infection)
  • Follow-up of less than 6 months
  • Patients with pre-existing peripheral neuropathy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Postoperative Pain Measured by Visual Analog Scale in Adult Patients Following Digital Amputation

    The primary objective of this study is to compare the level of postoperative pain associated with two surgical techniques: microanastomosis of digital nerves and traction neurectomy. Pain will be measured using the visual analog scale at one week, four weeks, and six months following the procedure. The visual analog scale ranges from 0 ( no pain) to 10 (worst imaginable pain).

    Time frame: 1 week, 4 weeks and 6 months

  2. Postoperative Symptoms Measured by the Disabilities of the Arm, Shoulder and Hand Questionnaire in Adult Patients Following Digital Amputation

    The secondary objective of this study is to compare the level of postoperative symptoms associated with two surgical techniques: microanastomosis of digital nerves and traction neurectomy. The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire will assess disability and hand-related symptoms at 6 months. The score ranges from 0 (no disability) to 100 (most severe disability)

    Time frame: 6 months

Secondary outcomes

  1. Complication Rate of Microanastomosis of Digital Nerves and Traction Neurectomy in Adult Patients Following Digital Amputation

    The tertiary objective of this study is to determine the incidence of postoperative complications for both microanastomosis of digital nerves and traction neurectomy.

    Time frame: 1 week, 4 weeks, 6 months

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Dec 2025 (actual). Primary completion is estimated for Jul 2027, 19 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Jul 2026 → Jul 2027 and completion Jul 2026 → Jul 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2025
First posted
Aug 5, 2025
StartActual
Dec 1, 2025
Primary completionEst.
Jul 1, 2027was Jul 2026
CompletionEst.
Jul 1, 2027was Jul 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Enrolling by invitation
changed Nov 16, 2026
Sites
1 site added — first site in Canada
Show site
  • CHUM · Montreal, Canada
Nov 16, 2026
Primary completion
Jul 1, 2026→Jul 1, 2027
Nov 16, 2026
Study completion
Jul 1, 2026→Jul 1, 2027
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Not yet recruiting→Enrolling by invitation
    1 site added — first site in Canada
    Show site
    • CHUM · Montreal, Canada
    Primary completion Jul 1, 2026→Jul 1, 2027
    Study completion Jul 1, 2026→Jul 1, 2027
    + 2 other changes: verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07102654
Responsible party
Sponsor
First posted
Aug 5, 2025
Start date
Dec 1, 2025
Primary completion
Jul 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Nov 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion